 |
Debio 8206
Hormone-dependent Prostate Cancer, LHRH agonist
|  | | | | |  |
Debio 8609, Sanvar®
Esophageal variceal bleeding, Somatostatin analog
| | | | | | |
Tremelimumab (codevelopment with Pfizer Inc.)
Oncology, Monoclonal antibody
| | | | |  |  |
Debio 025 (licenced to Novartis worldwide except Japan)
HCV, Cyclophilin inhibitor
| | | |  | | |
Debio 0507
Oncology, Platinum micellar nanoparticles
| | | | | | |
Debio 0827
Chronic pain, Enkephalinase inhibitor
| | | | | | |
Debio 0932
Oncology, Hsp90 inhibitor
| | | | | | |
Debio 0719
Oncology, LPA receptors antagonist
| | | | | | |
Debio 0928
Oncology, Raf1-Rb inhibitor
| | | | | | |
Debio 0617
Oncology, undisclosed target
|  | | | | | |
Debio 0930
Metabolic diseases, AMPK activator
| | | | | | |
Debio 0826
Oncology, undisclosed target
| | | | | | |
Debio 0721
Undisclosed target
| | | | | | |
Debio 0929
Oncology, undisclosed target
| | | | | | | 
